Key facts
- TYME TECHNOLOGIES, INC. has 15 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 23 May 2025.
$0
Shares: 0
Insiders: 0
$0
Shares: 0
Insiders: 0
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Michael Demurjian | 10%+ Owner | $5,434,866 | Filing P/S | 06 Sep 2022 | ||
| Paul L. Sturman | Director | Mixed | 24 Aug 2021 | |||
| Douglas A. Michels | Director | Mixed | 16 Sep 2022 | |||
| Timothy Tyson | Director | Mixed | 16 Sep 2022 | |||
| James Biehl | Chief Legal Officer | Mixed | 16 Sep 2022 | |||
| David Carberry | Director | Mixed | 16 Sep 2022 | |||
| Steve Hoffman | Director, 10%+ Owner | Mixed | 16 Sep 2022 | |||
| Frank L. Porfido | Chief Financial Officer | Mixed | 16 Sep 2022 | |||
| Richard Anthony Cunningham | Chief Executive Officer | Mixed | 16 Sep 2022 | |||
| Jonathan Eckard | Chief Business Officer | Mixed | 16 Sep 2022 | |||
| Barbara Galaini | Principal Accounting Officer and Controller | Mixed | 16 Sep 2022 | |||
| Donald W. DeGolyer | Director | Mixed | 16 Sep 2022 | |||
| Gerald H. Sokol | Director | Mixed | 16 Sep 2022 | |||
| Jan M. van Tornout | Acting Chief Medical Officer | Mixed | 22 Apr 2022 | |||
| Christine D. Baker | Director | Mixed | 16 Sep 2022 |
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Michael Demurjian |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
22,448,846
|
$5,434,866 | — | 06 Sep 2022 | |
| Jan M. van Tornout |
3/4/5
|
Acting Chief Medical Officer |
—
class O/S missing
|
240,000
|
— | — | 22 Apr 2022 | |
| Paul L. Sturman |
3/4/5
|
Director |
—
class O/S missing
|
88,000
|
— | — | 24 Aug 2021 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||